Direct evidence for an important species difference in the mechanism of 8-OH-DPAT-induced hypothermia - PubMed (original) (raw)

Direct evidence for an important species difference in the mechanism of 8-OH-DPAT-induced hypothermia

D J Bill et al. Br J Pharmacol. 1991 Aug.

Abstract

1. Parallel series of experiments were carried out in the rat and mouse in order to investigate the mechanism(s) underlying the hypothermia induced in rodents by the selective 5-HT1A receptor agonist, 8-hydroxy-2-(di-n-propylamino)tetralin (8-OH-DPAT). 2. In the mouse, lesioning of central 5-hydroxytryptaminergic neurones (by use of the neurotoxin, 5,7-dihydroxytryptamine; 5,7-DHT) abolished the hypothermic response to 8-OH-DPAT, and depletion of brain 5-hydroxytryptamine (5-HT) levels (with the 5-HT synthesis inhibitor, p-chlorophenylalanine) markedly attenuated the response in this species. These pretreatments did not significantly attenuate 8-OH-DPAT-induced hypothermia in the rat, except for a significant attenuation of the response in 5,7-DHT-lesioned rats at the top dose of 8-OH-DPAT (1.0 mg kg-1, s.c.). 3. Pharmacological pretreatments which facilitate 5-HT release (selective 5-HT uptake inhibitors, precursor (5-hydroxytryptophan) loading, or fenfluramine), markedly attenuated or abolished 8-OH-DPAT-induced hypothermia in the mouse. These pretreatments generally had no significant effect on 8-OH-DPAT-induced hypothermia in the rat. 4. The selective noradrenaline uptake inhibitor, desipramine, had no effect on the hypothermic response to 8-OH-DPAT in either species. The selective dopamine uptake inhibitor, nomifensin, significantly increased the hypothermic response to 8-OH-DPAT in the mouse, but did not affect the response in the rat except at high, motor stimulant doses, when the response was attenuated. 5. These data are consistent with the hypothesis that 8-OH-DPAT-induced hypothermia is mediated by presynaptic autoreceptors in the mouse and by postsynaptic 5-HT1A receptors in the rat. Preliminary data also indicate an involvement of dopamine release in the mouse but not in the rat.

PubMed Disclaimer

Similar articles

• Mediation of the antidepressant-like effect of 8-OH-DPAT in mice by postsynaptic 5-HT1A receptors.
  Luscombe GP, Martin KF, Hutchins LJ, Gosden J, Heal DJ. Luscombe GP, et al. Br J Pharmacol. 1993 Mar;108(3):669-77. doi: 10.1111/j.1476-5381.1993.tb12859.x. Br J Pharmacol. 1993. PMID: 8467355 Free PMC article.
• A behavioural and biochemical study in mice and rats of putative selective agonists and antagonists for 5-HT1 and 5-HT2 receptors.
  Goodwin GM, Green AR. Goodwin GM, et al. Br J Pharmacol. 1985 Mar;84(3):743-53. doi: 10.1111/j.1476-5381.1985.tb16157.x. Br J Pharmacol. 1985. PMID: 2580582 Free PMC article.
• The effect of putative 5-HT1A receptor antagonists on 8-OH-DPAT-induced hypothermia in rats and mice.
  Moser PC. Moser PC. Eur J Pharmacol. 1991 Feb 7;193(2):165-72. doi: 10.1016/0014-2999(91)90032-l. Eur J Pharmacol. 1991. PMID: 1828767
• Effects of tryptophan and of 5-hydroxytryptamine receptor subtype agonists on feeding.
  Curzon G. Curzon G. Adv Exp Med Biol. 1991;294:377-88. doi: 10.1007/978-1-4684-5952-4_35. Adv Exp Med Biol. 1991. PMID: 1837683 Review.
• Sex differences in neurochemical and behavioural effects of 8-hydroxy-2-(di-n-propylamino) tetralin.
  Haleem DJ. Haleem DJ. Life Sci. 1992;50(24):PL221-6. doi: 10.1016/0024-3205(92)90554-3. Life Sci. 1992. PMID: 1534597 Review.

Cited by

• VGLUT3 (vesicular glutamate transporter type 3) contribution to the regulation of serotonergic transmission and anxiety.
  Amilhon B, Lepicard E, Renoir T, Mongeau R, Popa D, Poirel O, Miot S, Gras C, Gardier AM, Gallego J, Hamon M, Lanfumey L, Gasnier B, Giros B, El Mestikawy S. Amilhon B, et al. J Neurosci. 2010 Feb 10;30(6):2198-210. doi: 10.1523/JNEUROSCI.5196-09.2010. J Neurosci. 2010. PMID: 20147547 Free PMC article.
• Sexually dimorphic serotonergic dysfunction in a mouse model of Huntington's disease and depression.
  Renoir T, Zajac MS, Du X, Pang TY, Leang L, Chevarin C, Lanfumey L, Hannan AJ. Renoir T, et al. PLoS One. 2011;6(7):e22133. doi: 10.1371/journal.pone.0022133. Epub 2011 Jul 8. PLoS One. 2011. PMID: 21760962 Free PMC article.
• Evidence for postsynaptic mediation of the hypothermic effect of 5-HT1A receptor activation.
  O'Connell MT, Sarna GS, Curzon G. O'Connell MT, et al. Br J Pharmacol. 1992 Jul;106(3):603-9. doi: 10.1111/j.1476-5381.1992.tb14382.x. Br J Pharmacol. 1992. PMID: 1387027 Free PMC article.
• Reduction in the density and expression, but not G-protein coupling, of serotonin receptors (5-HT1A) in 5-HT transporter knock-out mice: gender and brain region differences.
  Li Q, Wichems C, Heils A, Lesch KP, Murphy DL. Li Q, et al. J Neurosci. 2000 Nov 1;20(21):7888-95. doi: 10.1523/JNEUROSCI.20-21-07888.2000. J Neurosci. 2000. PMID: 11050108 Free PMC article.
• The effect of 5-HT1A receptor agonists on locomotor activity in the guinea-pig.
  Evenden JL. Evenden JL. Br J Pharmacol. 1994 Jul;112(3):861-6. doi: 10.1111/j.1476-5381.1994.tb13159.x. Br J Pharmacol. 1994. PMID: 7921613 Free PMC article.

References

1. 1. Neuropharmacology. 1985 Dec;24(12):1187-94 - PubMed
2. 1. Eur J Pharmacol. 1987 Nov 10;143(2):221-8 - PubMed
3. 1. Naunyn Schmiedebergs Arch Pharmacol. 1986 Jan;332(1):1-7 - PubMed
4. 1. J Neural Transm. 1985;61(1-2):131-5 - PubMed
5. 1. Neuropharmacology. 1986 Dec;25(12):1307-13 - PubMed

MeSH terms

Substances

LinkOut - more resources

• Full Text Sources

  • Europe PubMed Central
  • PubMed Central
  • Wiley